Nasiru Eneji

Hailing from Nigeria, Nasiru Eneji Abdulrasheed stands as a distinguished political scientist and a seasoned journalist for BNN Nigeria. Backed by robust academic credentials and a vast journalistic journey, he offers razor-sharp analysis and in-depth insights into global occurrences. Nasiru's profound expertise enriches the newsroom, ensuring a nuanced understanding of the complex tapestry of international affairs. 29 mins Conflict at People's Park: Student Housing Project Triggers Confrontation

Biography:  https://bnnbreaking.com/author/nasiru-eneji/

54%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

75%

Examples:

  • FDA Probes into Potential Health Risks of GLP-1 RA Medications
  • The present surveillance activities undertaken by the FDA are routine post-approval safety measures, intended to identify adverse effects unobserved during clinical trials.

Conflicts of Interest

50%

Examples:

Contradictions

85%

Examples:

  • Ozempic, Wegovy, Mounjaro, and Zepbound are the medications under investigation by the FDA.
  • The author states that GLP-1 RA medications are widely prescribed for weight loss and diabetes treatment when they have only been approved by the FDA for treating type 2 diabetes. This is a lie of omission.

Deceptions

30%

Examples:

Recent Articles

FDA Investigates Unusual Side Effects of Diabetes, Weight Loss Drugs

FDA Investigates Unusual Side Effects of Diabetes, Weight Loss Drugs

Broke On: Wednesday, 03 January 2024 The FDA is currently investigating reports of hair loss and suicidal thoughts in people using popular diabetes and weight loss drugs, including Ozempic, Mounjaro, Wegovy, Rybelsus. These medications mimic GLP-1 hormone naturally produced in the body.